PDS Planning’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-421
| Closed | -$267K | – | 529 |
|
|
2025
Q1 | $267K | Buy |
421
+83
| +25% | +$52.6K | 0.02% | 353 |
|
|
2024
Q4 | $241K | Sell |
338
-21
| -6% | -$15K | 0.02% | 355 |
|
|
2024
Q3 | $377K | Buy |
359
+3
| +0.8% | +$3.15K | 0.03% | 245 |
|
|
2024
Q2 | $374K | Buy |
356
+2
| +0.6% | +$2.1K | 0.04% | 220 |
|
|
2024
Q1 | $341K | Buy |
354
+17
| +5% | +$16.4K | 0.04% | 228 |
|
|
2023
Q4 | $296K | Sell |
337
-1
| -0.3% | -$878 | 0.03% | 235 |
|
|
2023
Q3 | $278K | Buy |
338
+26
| +8% | +$21.4K | 0.04% | 222 |
|
|
2023
Q2 | $224K | Sell |
312
-60
| -16% | -$43.1K | 0.03% | 271 |
|
|
2023
Q1 | $306K | Buy |
372
+17
| +5% | +$14K | 0.04% | 193 |
|
|
2022
Q4 | $256K | Sell |
355
-14
| -4% | -$10.1K | 0.04% | 165 |
|
|
2022
Q3 | $254K | Sell |
369
-1
| -0.3% | -$688 | 0.05% | 155 |
|
|
2022
Q2 | $219K | Buy |
370
+43
| +13% | +$25.5K | 0.04% | 180 |
|
|
2022
Q1 | $228K | Buy |
+327
| New | +$228K | 0.04% | 187 |
|